China Universal Asset Management Co., Ltd. Crinetics Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 19,664 shares of CRNX stock, worth $772,795. This represents 0.1% of its overall portfolio holdings.
Number of Shares
19,664
Previous 15,393
27.75%
Holding current value
$772,795
Previous $786,000
27.86%
% of portfolio
0.1%
Previous 0.09%
Shares
15 transactions
Others Institutions Holding CRNX
# of Institutions
243Shares Held
80.1MCall Options Held
23.3KPut Options Held
44.3K-
Vanguard Group Inc Valley Forge, PA6.29MShares$247 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$245 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.89MShares$231 Million2.95% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.94MShares$194 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA4.46MShares$175 Million0.04% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.11B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...